TRAVERE THERAPEUTICS, INC. Operating Leases, Future Minimum Payments, Due in Rolling Year Two and Three
TRAVERE THERAPEUTICS, INC. (TVTX) had Operating Leases, Future Minimum Payments, Due in Rolling Year Two and Three of $4.76 million as of 2017-12-31, per its 10-K filed 2018-07-06.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInRollingYearTwoAndThree · last filed 2018-07-06
- 2017-12-31: Operating Leases, Future Minimum Payments, Due in Rolling Year Two and Three $4.76M.
- 2017-09-30: Operating Leases, Future Minimum Payments, Due in Rolling Year Two and Three $4.82M.
- 2017-06-30: Operating Leases, Future Minimum Payments, Due in Rolling Year Two and Three $2.62M.
- 2017-03-31: Operating Leases, Future Minimum Payments, Due in Rolling Year Two and Three $2.75M.
| Period end | Operating Leases, Future Minimum Payments, Due in Rolling Year Two and Three | Operating Leases, Future Minimum Payments, Due in Rolling Year Two and Three as first filed |
|---|---|---|
| 2017-12-31 | $4.76M 10-K · filed 2018-07-06 | |
| 2017-09-30 | $4.82M 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $2.62M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $2.75M 10-Q · filed 2017-05-05 | |
| 2016-09-30 | $3.14M 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $1.09M 10-Q · filed 2016-08-05 | |
| 2016-03-31 | $1.37M 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $2.87M 10-K · filed 2017-03-01 | $1.65M 10-K · filed 2016-02-26 |
| 2015-09-30 | $1.05M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $1.05M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $1.32M 10-Q · filed 2015-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |